title: Effects of in vivo treatment with diphenyl ditelluride on the phosphorylation of cytoskeletal proteins in cerebral cortex and hippocampus of rats.
abstract: In this work, we investigated the effect of a single subcutaneous injection of diphenyl ditelluride (PheTe)(2) in 15-day-old Wistar rats (0.3 micromol/kg body weight) on the phosphorylation of intermediate filament (IF) proteins in cerebral cortex and hippocampus, 1, 3 or 6 days after injection. Results showed that 3 and 6 days after injection with (PheTe)(2), animals presented loss of body weight and cortical hyperphosphorylation of neurofilament subunits, glial fibrillary acidic protein (GFAP) and vimentin (Vim), the neuronal and glial intermediate filaments, respectively. Otherwise, in hippocampus, only GFAP and Vim were hyperphosphorylated and this effect was evidenced 6 days after injection. In cerebral cortex, hyperphosphorylation was accompanied by increased immunocontent of these proteins both in tissue homogenate and in cytoskeletal fraction, while in hippocampus only the immunocontent of cytoskletal-associated GFAP was increased. Moreover, hyperphosphorylation of cortical IF proteins, induced by (PheTe)(2), was totally reversed by a single subcutaneous injection of diphenyl diselenide (PheSe)(2) (5mumol/kg body weight) 24h after (PheTe)(2) administration. Taken together, our results suggest that cortical cytoskeleton is more susceptible to (PheTe)(2) than hippocampal cytoskeleton. Moreover, cytoskeletal dysfunction in cortical and hippocampal cells could be involved in the neurotoxicity induced by acute treatment with (PheTe)(2).
authors.affiliation: Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos 2600 anexo, 90035-003 Porto Alegre, RS, Brazil.
authors.forename: Luana
authors.initials: L
authors.lastname: Heimfarth
authors.forename: Samanta Oliveira
authors.initials: SO
authors.lastname: Loureiro
authors.forename: Ariane
authors.initials: A
authors.lastname: Zamoner
authors.forename: Priscila de Lima
authors.initials: Pde L
authors.lastname: Pelaez
authors.forename: Cristina Wayne
authors.initials: CW
authors.lastname: Nogueira
authors.forename: João Batista Teixeira da
authors.initials: JB
authors.lastname: Rocha
authors.forename: Regina
authors.initials: R
authors.lastname: Pessoa-Pureur
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000831:Animals, Newborn; D001555:Benzene Derivatives / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000187:drug effects*; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects*; D066298:In Vitro Techniques; D009942:Organometallic Compounds / Q000494:pharmacology*; D010766:Phosphorylation / Q000187:drug effects; D011868:Radioisotopes / Q000378:metabolism; D051381:Rats; D013997:Time Factors; D014746:Vimentin / Q000378:metabolism
chemical_list: D001555:Benzene Derivatives; D003598:Cytoskeletal Proteins; D005904:Glial Fibrillary Acidic Protein; D009942:Organometallic Compounds; D011868:Radioisotopes; D014746:Vimentin; C434247:diphenylditelluride